Ferroptosis-mitochondria-related molecular subtypes and prognostic signature reveal immune and pathway heterogeneity in hepatocellular carcinoma

doi:10.4251/wjgo.124061

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 11

This Article

(7)

(6)

(0)

(212)

Peer-Review Report of This Article

Supplementary Materials of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Nov 15, 2026; 18(11): 124061
Published online Nov 15, 2026. doi: 10.4251/wjgo.124061

Full Size Figure Download Figure

Figure 7 Hallmark pathway enrichment analysis of the ferroptosis-mitochondria-related risk signature. A: Gene set variation analysis heatmap of differentially enriched Hallmark pathways; B: Boxplots of representative Hallmark pathways; C: Bar plot of normalized enrichment scores from gene set enrichment analysis; D-F: Gene set enrichment analysis plots for MYC targets V1, E2F targets, and MYC targets V2. GSEA: Gene set enrichment analysis; GSVA: Gene set variation analysis.

Citation: Han S, Feng ZW, Ran Y, Ma GP, Zhou YC, Lv JZ, Li XB, Wang CH, Wang LZ, Hu SP. Ferroptosis-mitochondria-related molecular subtypes and prognostic signature reveal immune and pathway heterogeneity in hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(11): 124061
URL: https://www.wjgnet.com/1948-5204/full/v18/i11/124061.htm
DOI: https://dx.doi.org/10.4251/wjgo.124061

Han S, Feng ZW, Ran Y, Ma GP, Zhou YC, Lv JZ, Li XB, Wang CH, Wang LZ, Hu SP. Ferroptosis-mitochondria-related molecular subtypes and prognostic signature reveal immune and pathway heterogeneity in hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(11): 124061 [DOI: 10.4251/wjgo.124061]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.